This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2017 Jul 6;377(1):62-70.

doi: 10.1056/NEJMra1510062.

Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both

Janet Woodcock¹, Lisa M LaVange¹

Affiliations

PMID: 28679092
DOI: 10.1056/NEJMra1510062

Free article

Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both

Janet Woodcock et al. N Engl J Med. 2017.

Free article

. 2017 Jul 6;377(1):62-70.

doi: 10.1056/NEJMra1510062.

Authors

Janet Woodcock¹, Lisa M LaVange¹

Affiliation

¹ From the Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD.

PMID: 28679092
DOI: 10.1056/NEJMra1510062

No abstract available

PubMed Disclaimer

Similar articles

The Master Protocol Concept.
Redman MW, Allegra CJ. Redman MW, et al. Semin Oncol. 2015 Oct;42(5):724-30. doi: 10.1053/j.seminoncol.2015.07.009. Epub 2015 Jul 10. Semin Oncol. 2015. PMID: 26433553 Free PMC article. Review.
The investigational drug steering committee.
Ratain MJ. Ratain MJ. Clin Adv Hematol Oncol. 2007 Oct;5(10):779-80. Clin Adv Hematol Oncol. 2007. PMID: 17998895 No abstract available.
Statistics and logistics: Design of Ebola vaccine trials in West Africa.
Nason M. Nason M. Clin Trials. 2016 Feb;13(1):87-91. doi: 10.1177/1740774515620612. Epub 2016 Jan 14. Clin Trials. 2016. PMID: 26768560 No abstract available.
An experimental design for the development of adaptive treatment strategies.
Murphy SA. Murphy SA. Stat Med. 2005 May 30;24(10):1455-81. doi: 10.1002/sim.2022. Stat Med. 2005. PMID: 15586395
Choosing cases and controls: the clinical epidemiology of "clinical investigation".
Feinstein AR, Horwitz RI. Feinstein AR, et al. J Clin Invest. 1988 Jan;81(1):1-5. doi: 10.1172/JCI113279. J Clin Invest. 1988. PMID: 3275691 Free PMC article. Review. No abstract available.

See all similar articles

Cited by

Mobilizing the clinical trial ecosystem to drive adoption of master protocols.
Bronson A, Chase MK, Fisher K, Millar D, Perlmutter J, Richardson N. Bronson A, et al. Clin Trials. 2022 Dec;19(6):690-696. doi: 10.1177/17407745221110199. Epub 2022 Sep 9. Clin Trials. 2022. PMID: 36086812 Free PMC article.
The Landscape of Signaling Pathways and Proteasome Inhibitors Combinations in Multiple Myeloma.
Paradzik T, Bandini C, Mereu E, Labrador M, Taiana E, Amodio N, Neri A, Piva R. Paradzik T, et al. Cancers (Basel). 2021 Mar 11;13(6):1235. doi: 10.3390/cancers13061235. Cancers (Basel). 2021. PMID: 33799793 Free PMC article. Review.
Clinical cancer genomic profiling.
Chakravarty D, Solit DB. Chakravarty D, et al. Nat Rev Genet. 2021 Aug;22(8):483-501. doi: 10.1038/s41576-021-00338-8. Epub 2021 Mar 24. Nat Rev Genet. 2021. PMID: 33762738 Review.
Gaps and opportunities in sepsis translational research.
Marshall JC, Leligdowicz A. Marshall JC, et al. EBioMedicine. 2022 Dec;86:104387. doi: 10.1016/j.ebiom.2022.104387. Epub 2022 Dec 2. EBioMedicine. 2022. PMID: 36470831 Free PMC article. Review.
Contribution of Predictive and Prognostic Biomarkers to Clinical Research on Chronic Kidney Disease.
Provenzano M, Rotundo S, Chiodini P, Gagliardi I, Michael A, Angotti E, Borrelli S, Serra R, Foti D, De Sarro G, Andreucci M. Provenzano M, et al. Int J Mol Sci. 2020 Aug 14;21(16):5846. doi: 10.3390/ijms21165846. Int J Mol Sci. 2020. PMID: 32823966 Free PMC article. Review.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information